Icon Wealth Advisors LLC Sells 5,827 Shares of CME Group Inc. (NASDAQ:CME)

Icon Wealth Advisors LLC reduced its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 94.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 325 shares of the financial services provider’s stock after selling 5,827 shares during the quarter. Icon Wealth Advisors LLC’s holdings in CME Group were worth $72,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in CME. Wealth Enhancement Advisory Services LLC raised its holdings in CME Group by 21.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after acquiring an additional 8,443 shares in the last quarter. Cetera Investment Advisers boosted its holdings in CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after acquiring an additional 38,540 shares during the last quarter. Brookstone Capital Management increased its position in shares of CME Group by 12.2% during the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after buying an additional 3,325 shares during the period. Mather Group LLC. lifted its stake in shares of CME Group by 197.2% in the 2nd quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider’s stock valued at $1,306,000 after purchasing an additional 4,025 shares during the period. Finally, Hennion & Walsh Asset Management Inc. lifted its position in shares of CME Group by 40.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 10,742 shares of the financial services provider’s stock valued at $2,112,000 after acquiring an additional 3,112 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 over the last quarter. 0.30% of the stock is owned by insiders.

CME Group Trading Up 1.1 %

Shares of CME Group stock opened at $229.04 on Monday. The company has a market cap of $82.54 billion, a P/E ratio of 24.08, a price-to-earnings-growth ratio of 5.23 and a beta of 0.55. The firm has a 50-day simple moving average of $223.64 and a two-hundred day simple moving average of $211.08. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.74.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.25 EPS. As a group, equities analysts predict that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.01%. CME Group’s payout ratio is currently 48.37%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CME. The Goldman Sachs Group boosted their price objective on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Oppenheimer upped their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Barclays raised their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. TD Cowen initiated coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $224.47.

Get Our Latest Analysis on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.